Barinthus Biotherapeutics plc (BRNS) Misses Q2 EPS by 3c
Tweet
Share
E-mailGet Alerts BRNS Hot Sheet
Join SI Premium – FREE
Barinthus Biotherapeutics plc (NASDAQ: BRNS) reported Q2 EPS of ($0.43), $0.03 worse than the analyst estimate of ($0.40).
For earnings history and earnings-related data on Barinthus Biotherapeutics plc (BRNS) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Barrick Mining said to delay IPO of American gold business to 2027
- Fjordland Announces Consolidation
- From the Open Road to the Crossroads of the World: Roadtrippers and Campendium Light Up Times Square
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
